A new study finds SGLT2 inhibitors like Jardiance and GLP-1 drugs like Ozempic provide different benefits depending on the ...

GLP-1 receptor agonists were more cardioprotective in younger people, but reduced HbA1c more with age. The age of type 2 ...

The matter came up in connection to the patent rights of the German company for its antidiabetic drug linagliptin, which has seen its patent (in the present dispute) expired on August 18, 2023. The ...

Glyxambi (empagliflozin/linagliptin) has potential interactions with other medications and some supplements. These interactions could affect how well the drug works ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...

The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...